Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-15 Sale | 2024-03-18 5:45 pm | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 3,524 | $72.69 | $256,160 | 36,476 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-16 Option Award | 2024-10-18 5:35 pm | N/A 2034-10-16 | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 33,333 | $0 | 33,333 (Direct) | View |
2024-03-20 Option Award | 2024-03-22 5:45 pm | N/A 2034-03-20 | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 61,168 | $0 | 61,168 (Direct) | View |
2024-03-14 Exercise | 2024-03-18 5:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 10,000 | $0 | 36,476 (Direct) | View |
2023-10-13 Option Award | 2023-10-17 5:52 pm | N/A 2033-10-13 | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 13,832 | $0 | 13,832 (Direct) | View |
2023-03-14 Option Award | 2023-03-14 5:50 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 140,000 | $0 | 140,000 (Direct) | View |